Home › Research › How common it is
Prevalence and incidence of Alzheimer's disease in Europe: A meta-analysis
Niu H, Álvarez-Álvarez I, Guillén-Grima F, Aguinaga-Ontoso I.. Neurologia (Barcelona, Spain), 2016-04-26
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Background A disease of unknown aetiology, Alzheimer's disease (AD) is the most common type of dementia. As the elderly population grows worldwide, the number of patients with AD also increases rapidly. The aim of this meta-analysis is to evaluate the prevalence and incidence of AD in Europe. Methodology We conducted a literature search on Medline, Scopus, and CINAHL Complete using the keywords «Alzheimer», «Alzheimer's disease», and «AD» combined with «prevalence», «incidence», and «epidemiology». A Bayesian random effects model with 95% credible intervals was used. The I 2 statistic was applied to assess heterogeneity. Results The prevalence of Alzheimer's disease in Europe was estimated at 5.05% (95% CI, 4.73-5.39). The prevalence in men was 3.31% (95% CI, 2.85-3.80) and in women, 7.13% (95% CI, 6.56-7.72), and increased with age. The incidence of Alzheimer's disease in Europe was 11.08 per 1000 person-years (95% CI, 10.30-11.89). Broken down by sex, it was 7.02 per 1000 person-years (95% CI, 6.06-8.05) in men and 13.25 per 1000 person-years (95% CI, 12.05-14.51) in women; again these rates increased with age. Conclusions The results of our meta-analysis allow a better grasp of the impact of this disease in Europe.
What this study adds
Evidence grade: High
This is a pooled review. This analysis estimated how common and how frequently new Alzheimer's disease cases occur in Europe, with rates higher in women and rising with age. Reported effect size: 5.05%; 3.31%; 7.13%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Niu, H., Álvarez-Álvarez, I., Guillén-Grima, F., & Aguinaga-Ontoso, I. (2017). Prevalence and incidence of Alzheimer's disease in Europe: A meta-analysis. Neurologia (Barcelona, Spain). https://doi.org/10.1016/j.nrl.2016.02.016
Vancouver
Niu H, Álvarez-Álvarez I, Guillén-Grima F, Aguinaga-Ontoso I. Prevalence and incidence of Alzheimer's disease in Europe: A meta-analysis. Neurologia (Barcelona, Spain). 2017. doi:10.1016/j.nrl.2016.02.016. PMID: 27130306.
BibTeX
@article{niu2017-27130306,
author = {Niu, H. and Álvarez-Álvarez, I. and Guillén-Grima, F. and Aguinaga-Ontoso, I.},
title = {{Prevalence and incidence of Alzheimer's disease in Europe: A meta-analysis}},
journal = {Neurologia (Barcelona, Spain)},
year = {2017},
doi = {10.1016/j.nrl.2016.02.016},
pmid = {27130306},
url = {https://doi.org/10.1016/j.nrl.2016.02.016}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Results The prevalence of Alzheimer's disease in Europe was estimated at 5.05% (95% CI, 4.73-5.39).
- Conclusions The results of our meta-analysis allow a better grasp of the impact of this disease in Europe.
Why it matters
This analysis estimated how common and how frequently new Alzheimer's disease cases occur in Europe, with rates higher in women and rising with age. It describes the scale of the disease and does not address treatment, cure or prevention.
New to this subject? Start with our plain-English guide: Alzheimer's in numbers →
Study details
- Study designmeta-analysis
- Effect size5.05%; 3.31%; 7.13%
- Evidence strengthHigh
How this study scored 62/100
Published in a peer-reviewed journal, and it is a meta-analysis pooling many studies. Scored zero for sample size and studied in people because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Neurologia (Barcelona, Spain)) |
| Journal's citation record | 0 / 4 | Neurología: journal h-index 54 (OpenAlex, 2026-10-29) |
| Study design | 12 / 12 | A meta-analysis pooling many studies |
| Strength of evidence | 5 / 5 | Rated “high” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 2 / 5 | 2017 — within 10 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | A review of other studies — randomization is not credited here |
| Times cited | 6 / 7 | Cited 413 times (OpenAlex, 2026-10-10) |
| Citations per year | 4 / 5 | 37.5 citations a year over 11 year(s) since 2017 |
| Impact for its field and year | 4 / 6 | Cited 15.3× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 2 / 6 | Cited by 5 other studies in this library |
| Still being cited | 3 / 4 | Cited 144 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Inés Aguinaga-Ontoso: h-index 28 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Clinica Universidad de Navarra: institution h-index 435 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 3 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 27130306) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 62 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 24.
Later studies that cite this one
5 studies in the alzhub library list this one in their references.
Related studies in How common it is from nearby years
Also in How common it is
80 studies in the library are filed under How common it is with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The How common it is hub.